GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aequus Pharmaceuticals Inc (OTCPK:AQSZF) » Definitions » Accumulated Depreciation

Aequus Pharmaceuticals (Aequus Pharmaceuticals) Accumulated Depreciation : $-0.46 Mil (As of Sep. 2023)


View and export this data going back to 2015. Start your Free Trial

What is Aequus Pharmaceuticals Accumulated Depreciation?

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

Aequus Pharmaceuticals's quarterly accumulated depreciation increased from Sep. 2022 ($-0.34 Mil) to Dec. 2022 ($-0.38 Mil) and increased from Dec. 2022 ($-0.38 Mil) to Sep. 2023 ($-0.46 Mil).

Aequus Pharmaceuticals's annual accumulated depreciation increased from Dec. 2020 ($-0.24 Mil) to Dec. 2021 ($-0.31 Mil) and increased from Dec. 2021 ($-0.31 Mil) to Dec. 2022 ($-0.38 Mil).


Aequus Pharmaceuticals Accumulated Depreciation Historical Data

The historical data trend for Aequus Pharmaceuticals's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aequus Pharmaceuticals Accumulated Depreciation Chart

Aequus Pharmaceuticals Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Accumulated Depreciation
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.03 -0.14 -0.24 -0.31 -0.38

Aequus Pharmaceuticals Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Sep23
Accumulated Depreciation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.31 -0.33 -0.34 -0.38 -0.46

Aequus Pharmaceuticals Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.


Aequus Pharmaceuticals Accumulated Depreciation Related Terms

Thank you for viewing the detailed overview of Aequus Pharmaceuticals's Accumulated Depreciation provided by GuruFocus.com. Please click on the following links to see related term pages.


Aequus Pharmaceuticals (Aequus Pharmaceuticals) Business Description

Traded in Other Exchanges
Address
200 Granville Street, Suite 2820, Vancouver, BC, CAN, V6C 1S4
Aequus Pharmaceuticals Inc is a Canada-based specialty pharmaceutical company. The firm's operating segments are the Commercial platform and Development pipeline. It generates a majority of its revenue from the Commercial platform segment. The Company earns revenues from the sale of dry eye products and by providing promotional services to sell third-party-owned products, namely Tacrolimus IR and Vistitan.

Aequus Pharmaceuticals (Aequus Pharmaceuticals) Headlines

From GuruFocus

Aequus Provides General Update and Reports Record 2021 Financial Results

By GuruFocusNews GuruFocusNews 07-01-2022

Aequus Provides General Update and Fiscal 2022 Financial Results

By sperokesalga sperokesalga 05-02-2023

Aequus Provides General Update and Reports Record 2021 Financial Results

By GlobeNewswire GlobeNewswire 07-01-2022

Aequus Reports Third Quarter 2022 Financial Highlights

By GlobeNewswire GlobeNewswire 11-30-2022

Aequus Provides Update on Delay in Filing Annual Financial Statements

By GuruFocusNews GuruFocusNews 07-06-2022

Aequus Provides Update on Delay in Filing Annual Financial Statements

By GuruFocusNews GuruFocusNews 07-06-2022

Aequus Resumes Trading on TSX Venture Exchange

By PurpleRose PurpleRose 07-13-2022

Aequus Provides Update on Delay in Filing Annual Financial Statements

By GuruFocusNews GuruFocusNews 07-03-2022